Postherpetic neuralgia (PHN) is a common and often devastatingly painful condition. It is
also one of the most extensively investigated of the neuropathic pains. Patients with PHN …

Nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most commonly prescribed
drugs worldwide and are responsible for approximately one-quarter of all adverse drug …

The purpose of this review was to identify and analyze the controlled clinical trial data for
peripheral neuropathic pain (PNP) and complex regional pain syndromes (CRPS). A total of …

Background Postherpetic neuralgia (PHN) is a complication of acute herpes zoster, which is
emerging as a preferred clinical trial model for chronic neuropathic pain. Although there are …

With a focus on practical acute pain management in adults in the hospital setting, this book
provides health professionals with simple and practical information to help them manage …

Peripheral neuropathic pain syndromes (PNPS) are difficult to treat because commonly used
analgesics are often ineffective when, for example, touch-evoked allodynia, hyperalgesia …

A systematic review of the literature on postherpetic neuralgia was performed. The authors
identified studies using the National Library of Medicine's Medline database and Cochrane …

This health technology assessment evaluated the efficacy of pharmacological treatment in
patients with oro‐facial pain. Randomised controlled trials were included if they reported …

Oral analgesics are commonly prescribed for the treatment of acute and chronic pain, but
these agents often produce adverse systemic effects, which sometimes are severe. Topical …

The safety, tolerability, and efficacy of the lidocaine patch 5%(Lidoderm®), a targeted
peripheral analgesic with an FDA‐approved indication for the treatment of postherpetic …